What Is Perspective Therapeutics, Inc. (CATX) Worth in 2026?
According to the CirclFi Deep Alpha Valuation Engine, Perspective Therapeutics, Inc.'s intrinsic value is estimated at a composite fair value of $2.40. Trading at $3.22, the stock is approaching fair value or slight overvaluation (implied return of -25.4%), as 5 of 9 models suggest limited further upside. Notably, Sentiment SOTP sees the most upside at +35.6% (fair value: $4.36), while Regime Cross is the most conservative at -85.8% ($0.46). The spread between these extremes — +121.4% — reveals how different analytical frameworks can reach starkly different conclusions.
What Do the Models Say About CATX?
9 of 13 models are currently active for CATX. Of these, 3 models suggest upside while 6 models suggest overvaluation. The Bayesian DCF estimates CATX's intrinsic value at $0.83, implying -74.1% downside from the current price. See which stocks rank higher →
How Does CATX Rank in Pharmaceutical Preparations?
Among 431 Pharmaceutical Preparations stocks, CATX ranks #243 by Quality of Company score. CirclFi's QOC score of 4.8/10 evaluates 32 fundamental signals. A score of 4.8 reflects mixed fundamentals.
See all Most Undervalued Pharmaceutical Preparations Stocks →
The Pharmaceutical Preparations sector introduces analytical considerations specific to healthcare company businesses. For Perspective Therapeutics, Inc., metrics like patent cliff exposure provide important context that general-purpose valuation models may underweight.
Is CATX a Value Trap?
The Value Trap algorithm is not active for CATX. The score cross-references apparent undervaluation against fundamental deterioration signals. Browse lowest value-trap stocks →
Multi-Model Methodology
9 of 13 models are active for Perspective Therapeutics, Inc.. Moderate coverage provides meaningful perspective. Each model applies a fundamentally different valuation philosophy. See the complete methodology →
According to the CirclFi Deep Alpha Valuation Engine, Perspective Therapeutics, Inc. scores 4.8 out of 10 on our 32-signal quality assessment, a moderate rating that shows mixed signals across our quality framework with notable weaknesses. The QOC score synthesizes profitability margins, revenue growth reliability, debt management, and capital allocation into a single metric designed to separate durable businesses from statistically cheap ones.
The gap between the most bullish and bearish model spans +121.4% — demonstrating why single-model analysis is dangerous. Browse all stocks with 13-model coverage →
Data Sources & Confidence
Every CATX valuation is built from SEC EDGAR XBRL filings — 700+ standardized financial tags. Macroeconomic context from FRED calibrates discount rates, while GDELT news sentiment feeds into our Sentiment SOTP model. All pipelines run daily. Read the complete data methodology →
Across CATX's 9 active models, average confidence is 23%. Lower confidence may reflect limited history or high volatility.
CirclFi's output is a research starting point, not a buy/sell signal. All data updates daily. Read the full methodology →
Buy with Gumroad